Afficher la couverture 'Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. | Faivre, Laurence' en grand format
/5

0 avis

Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands.

Archive ouverte

Faivre, Laurence | Collod-Beroud, Gwenaëlle | Child, Anne, H. | Callewaert, Bert, L. | Loeys, Bart, L. | Binquet, Christine | Gautier, Elodie | Arbustini, Eloisa | Mayer, Karin | Arslan-Kirchner, Mine | Stheneur, Chantal | Kiotsekoglou, Anatoli | Comeglio, Paolo | Marziliano, Nicola | Halliday, Dorothy, J. | Béroud, Christophe | Bonithon-Kopp, Claire | Claustres, Mireille | Plauchu, Henri | Robinson, Peter, N. | Adès, Lesley, C. | de Backer, Julie | Coucke, Paul | Francke, Uta | de Paepe, Anne | Boileau, Catherine | Jondeau, Guillaume

Edité par CCSD ; BMJ Publishing Group -

International audience. BACKGROUND: The diagnosis of Marfan syndrome (MFS) is usually initially based on clinical criteria according to the number of major and minor systems affected following international nosology. The number of FBN1 mutation carriers, at risk of aortic complications who would not be properly diagnosed based only on clinical grounds, is of growing importance owing to the increased availability of molecular screening. The aim of the study was to identify patients who should be considered for FBN1 mutation screening. METHODS: Our international series included 1009 probands with a known FBN1 mutation. Patients were classified as either fulfilling or not fulfilling "clinical" criteria. In patients with unfulfilled "clinical" criteria, we evaluated the percentage of additional patients who became positive for international criteria when the FBN1 mutation was considered. The aortic risk was evaluated and compared in patients fulfilling or not fulfilling the "clinical" international criteria. RESULTS: Diagnosis of MFS was possible on clinical grounds in 79% of the adults, whereas 90% fulfilled the international criteria when including the FBN1 mutation. Corresponding figures for children were 56% and 85%, respectively. Aortic dilatation occurred later in adults with unfulfilled "clinical criteria" when compared to the Marfan syndrome group (44% vs 73% at 40 years, p<0.001), but the lifelong risk for ascending aortic dissection or surgery was not significantly different in both groups. CONCLUSIONS: Because of its implications for aortic follow-up, FBN1 molecular analysis is recommended in newly suspected MFS when two systems are involved with at least one major system affected. This is of utmost importance in patients without aortic dilatation and in children.

Suggestions

Du même auteur

Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study.

Archive ouverte | Faivre, Laurence | CCSD

International audience. Mutations in the fibrillin-1 (FBN1) gene cause Marfan syndrome (MFS) and have been associated with a wide range of overlapping phenotypes. Clinical care is complicated by variable age at onse...

Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation.

Archive ouverte | Faivre, Laurence | CCSD

International audience. Mutations in the FBN1 gene cause Marfan syndrome (MFS) and a wide range of overlapping phenotypes. The severe end of the spectrum is represented by neonatal MFS, the vast majority of probands...

Clinical and molecular study of 320 children with Marfan syndrome and related type I fibrillinopathies in a series of 1009 probands with pathogenic FBN1 mutations.

Archive ouverte | Faivre, Laurence | CCSD

International audience. From a large series of 1009 probands with pathogenic FBN1 mutations, data for 320 patients <18 years of age at the last follow-up evaluation were analyzed (32%). At the time of diagnosis, the...

Chargement des enrichissements...